ArticleScientific reports2026
Protium heptaphyllum, a tree native to the Atlantic Forest, is a potential source of compounds against important cocoa phytopathogen.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Given the growing demand for sustainable agricultural practices with less environmental impact, plant-derived essential oils (EOs) have gained attention as promising alternatives to control phytopathogens. Protium heptaphyllum Aubl. Marchand (amescla) is a tree species widely distributed in fragments of the Atlantic Forest, whose resin is rich in EOs. Different bioactivities have been attributed to the EO of P. heptaphyllum, mainly associated with antimicrobial activity in human health applications. However, there are still no studies investigating its potential to control plant diseases, especially pathogens of cacao (Theobroma cacao L.) This study evaluated the efficiency of P. heptaphyllum EO on the development of Moniliophthora perniciosa, the causal agent of witches' broom disease in cacao, as well as its effect on modulating its proteome. The chemical composition of the essential oil, determined by GC/MS, revealed predominance of monoterpenes, with emphasis on α-pinene (39.57%), δ-carene (21.42%), and β-pinene (9.56%). The antifungal activity assay was conducted in a completely randomized design, composed of different concentrations of the essential oil (0.05-12.8%) and two controls (PDA - potato dextrose agar and 1% Tween 80 on the surface of solidified PDA), with five replicates per treatment. The essential oil had a significant inhibitory effect on the mycelial growth of M. perniciosa at all concentrations evaluated (0.05-12.8%), compared to the controls. The greatest concentration tested (12.8%) resulted in the highest fungistatic activity, with a PIC (percentage of mycelial growth) of 73.8%. Hyphae treated with 0.8% essential oil (EO) showed intense red fluorescence after staining with propidium iodide (PI), in comparison with the control, indicating greater permeability of the cell membrane. Quantitative analysis of the PI-stained hyphae showed that approximately 97% exhibited red fluorescence, evidencing compromised plasma membrane integrity. In general, P. heptaphyllum essential oil, ha a low inhibitory effect on Lactuca sativa in all parameters evaluated (germination, root length, shoot length, fresh weight, dry weight, and electrical conductivity) without compromising seedling development. Proteomic analysis revealed modulation of the fungal proteome, highlighting ribosomal proteins, structural proteins, glycolytic metabolism proteins, and antioxidant response proteins. The results indicated that P. heptaphyllum essential oil is a promising sustainable alternative for the control of M. perniciosa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.